Related Experiment Video
Updated: May 30, 2026
09:29
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
New, strategic outsourcing models to meet changing clinical development needs
1Senior Director Project Information & Feasibility, ICON Clinical Research, Europe.
Perspectives in Clinical Research
|August 11, 2011
Summary
Pharmaceutical companies face rising clinical costs and regulatory demands. Strategic outsourcing and strong partnerships are key to managing budgets and increasing project success.
Area of Science:
- Pharmaceutical industry
- Drug development
- Clinical research
Background:
- Increasing clinical costs and stringent regulatory requirements challenge pharmaceutical companies.
- The need for robust efficacy data necessitates higher investment and strategic planning.
- Budget constraints drive the exploration of cost-containment strategies within the pharmaceutical sector.
Purpose of the Study:
- To examine the evolution of outsourcing strategies in the pharmaceutical industry.
- To identify key challenges and best practices in strategic outsourcing relationships.
- To explore transformational outsourcing models based on strong partnerships.
Main Methods:
- Analysis of evolving outsourcing models from tactical to strategic relationships.
- Examination of lessons learned from sponsor-contract research organization (CRO) partnerships.
- Detailed review of governance models and early planning in outsourcing.
Main Results:
- Pharmaceutical companies are shifting towards strategic outsourcing, involving historically core functions.
- Creative outsourcing approaches and transformational models are gaining traction.
- Strong partnerships, robust governance, and early commitment are critical for success.
Conclusions:
- Strategic outsourcing, characterized by strong partnerships and effective governance, is essential for pharmaceutical companies to navigate rising costs and regulatory hurdles.
- Bilateral central control through a strong governance model is crucial for managing complex outsourcing relationships.
- Early planning and commitment are vital components for successful strategic outsourcing initiatives.
Related Concept Videos
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:15Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:29Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...